Crescent Capital BDC (NASDAQ:CCAP) Stock Rating Lowered by LADENBURG THALM/SH SH

Crescent Capital BDC (NASDAQ:CCAP) was downgraded by investment analysts at LADENBURG THALM/SH SH from a “buy” rating to a “neutral” rating in a note issued to investors on Wednesday, Marketbeat reports. They presently have a $10.00 price objective on the stock. LADENBURG THALM/SH SH‘s price objective indicates a potential downside of 1.33% from the stock’s current price.

CCAP has been the subject of a number of other reports. Bank of America cut shares of Crescent Capital BDC from a “buy” rating to a “neutral” rating and reduced their price objective for the stock from $13.00 to $10.25 in a research report on Thursday, September 10th. Wells Fargo & Company dropped their price objective on shares of Crescent Capital BDC from $11.00 to $10.00 and set an “equal weight” rating on the stock in a research report on Wednesday. Keefe, Bruyette & Woods cut shares of Crescent Capital BDC from an “outperform” rating to a “market perform” rating and cut their target price for the stock from $13.00 to $12.00 in a research note on Monday, August 17th. Raymond James Financial set a $10.00 target price on shares of Crescent Capital BDC in a report on Thursday, October 22nd. Finally, Wall Street Zen raised shares of Crescent Capital BDC from a “sell” rating to a “hold” rating in a report on Saturday, October 10th. Seven analysts have rated the stock with a Hold rating. According to data from MarketBeat, the stock currently has a consensus rating of “Hold” and an average price target of $11.54.

Crescent Capital BDC Stock Performance

Shares of CCAP stock traded down $0.24 during trading on Wednesday, reaching $10.13. 14,148 shares of the company’s stock were exchanged, compared to its average volume of 230,152. The company has a quick ratio of 1.30, a current ratio of 1.30 and a debt-to-equity ratio of 1.41. The stock has a market capitalization of $373.47 million, a PE ratio of -1,012.50 and a beta of 0.56. Crescent Capital BDC has a twelve month low of $8.40 and a twelve month high of $15.18. The firm’s fifty day moving average price is $9.44 and its 200-day moving average price is $11.53.

Crescent Capital BDC (NASDAQ:CCAP) last posted its quarterly earnings results on Monday, November 9th. The company reported $0.37 earnings per share for the quarter, beating analysts’ consensus estimates of $0.35 by $0.02. Crescent Capital BDC had a positive return on equity of 8.66% and a negative net margin of 0.10%. The business had revenue of $36.89 million for the quarter, compared to analysts’ expectations of $36.37 million. As a group, sell-side analysts anticipate that Crescent Capital BDC will post 1.49 EPS for the current year.

Insider Activity

In related news, major shareholder & Guaranty Life Insur Fidelity sold 139,054 shares of the company’s stock in a transaction dated Wednesday, September 9th. The shares were sold at an average price of $10.23, for a total value of $1,422,522.42. Following the transaction, the insider directly owned 3,680,307 shares in the company, valued at approximately $37,649,540.61. This represents a 3.64% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 451,543 shares of company stock valued at $4,689,738 over the last three months. Insiders own 1.23% of the company’s stock.

Institutional Trading of Crescent Capital BDC

Hedge funds and other institutional investors have recently bought and sold shares of the business. Fidelity National Financial Inc. bought a new stake in Crescent Capital BDC in the 2nd quarter valued at about $45,922,000. Rivernorth Capital Management LLC bought a new position in shares of Crescent Capital BDC during the second quarter worth approximately $7,675,000. North Ground Capital bought a new position in shares of Crescent Capital BDC during the second quarter worth approximately $5,687,136. Beach Point Capital Management LP increased its holdings in shares of Crescent Capital BDC by 1,301.2% during the third quarter. Beach Point Capital Management LP now owns 515,892 shares of the company’s stock worth $4,736,000 after purchasing an additional 479,075 shares during the period. Finally, Almitas Capital LLC acquired a new stake in shares of Crescent Capital BDC in the second quarter valued at approximately $3,897,000. Institutional investors and hedge funds own 49.46% of the company’s stock.

Crescent Capital BDC News Roundup

Here are the key news stories impacting Crescent Capital BDC this week:

• Positive Sentiment: Quarterly results beat expectations. CCAP reported Q3 net investment income of $0.37 per share, above the $0.35 consensus, and revenue of $36.89 million versus estimates of $36.37 million. Earnings were still below $0.46 per share a year earlier. Q3 earnings report
• Positive Sentiment: Buyback and dividend may support shareholder returns. The company authorized a $50 million share repurchase program and declared a quarterly base dividend of $0.34 per share, equivalent to $1.36 annualized. The announced dividend yield was about 13.1%, though dividends and yields can change. Company earnings and capital-return announcement
• Neutral Sentiment: Analyst outlooks diverge. One Zacks report cited an average analyst price target implying 34.3% upside, while Wells Fargo lowered its target from $11 to $10 and kept an equal-weight rating. The target cut suggests limited near-term upside in that analyst’s view. Analyst consensus report
• Negative Sentiment: Buyout-lending activity weakened. Direct lending for buyouts fell 60% year over year, raising concerns about deal flow and future investment opportunities. Investors will also watch for the company’s targeted Q4 2026 joint-venture completion. Long-term investor takeaways

About Crescent Capital BDC

Crescent Capital BDC, Inc. is a business development company that provides financing to middle-market companies. The company seeks to generate current income and, to a lesser extent, capital appreciation by investing in privately negotiated debt and equity securities. Its investment portfolio is focused primarily on senior secured loans, including first-lien and second-lien loans, as well as other debt investments and selected equity interests. Crescent Capital BDC generally works with established companies across a range of industries, providing capital for acquisitions, recapitalizations, refinancing, growth initiatives and other corporate purposes.